Thursday August 26, 2010, 7:35 pm EDT
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences (NSDQ: USNA), a leader in nutritional supplement manufacturing, today announced that it will be one of the first companies in the industry to utilize Nutritional Hybrid Technology. This cutting-edge manufacturing method was unveiled to thousands of USANA independent Associates in attendance at the company’s international convention.
“USANA is proud to be a leader in the evolution of nutrition technology,” said Dr. Tim Wood, USANA Executive Vice President of Research and Development. “USANA’s Nutritional Hybrid Technology illustrates our commitment to innovative manufacturing practices and production of high-quality nutritional products.”
Through Nutritional Hybrid Technology, USANA can now combine two distinct formulas into one bilayered tablet, allowing for advanced ingredient combinations while providing product stability. The technology will also help consumers simplify their nutritional regimen by decreasing the number of tablets they take each day. Two new USANA formulas, Proflavanol® C100 and Hepasil DTX™, were created with the new manufacturing technology and also unveiled at the company’s convention.
Proflavanol C100 combines powerful proanthocyanidins from grape-seed extract with high-potency vitamin C to promote sound cardiovascular health, immune function, and healthy-looking skin. An in-house USANA study found that the combination of grape-seed extract and vitamin C in Proflavanol C100 provides long-term antioxidant activity and better protective effects than if they were not combined.
USANA’s upgraded Hepasil DTX formula contains a proprietary blend of ingredients to maintain optimum liver support and aid in the body’s detoxification processes. Nutritional Hybrid Technology allows USANA to boost key ingredients in the supplement while maintaining product quality and stability.
No comments:
Post a Comment